ANNIE CHANG: Open Payments
NPI 1992339881 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,608 in 129 payments from 18 companies in 2025. Trend: 2023 $1,600 · 2024 $1,253 · 2025 $2,608
Food & beverage: $2,457Education: $151
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 28 | $490 |
| Arcutis Biotherapeutics, Inc. | 27 | $377 |
| ABBVIE INC. | 17 | $276 |
| Janssen Biotech, Inc. | 10 | $239 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $162 |
| GENZYME CORPORATION | 5 | $146 |
| Organon LLC | 9 | $138 |
| Journey Medical Corporation | 1 | $124 |
| Novartis Pharmaceuticals Corporation | 6 | $122 |
| Botanix SB Inc | 1 | $113 |
Products named: ADBRY, Zoryve, TREMFYA, SKYRIZI, DUPIXENT, SOFDRA, ANZUPGO, VTAMA.
Industry payments across TX — which companies pay providers there.
